Mirae Asset Global ETFs Holdings’s AstraZeneca AZN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Sell	60,478 -7,563	-11%	-$1.42M	0.01%	639
2026 Q1	$13.4M	Sell	68,041 -142,519	-68%	-$27.5M	0.02%	574
2025 Q4	$38.7M	Sell	210,560 -2,672	-1%	-$469K	0.06%	302
2025 Q3	$32.7M	Sell	213,232 -22,799	-10%	-$3.45M	0.05%	326
2025 Q2	$33M	Sell	236,031 -8,511	-3%	-$1.19M	0.06%	285
2025 Q1	$35.9M	Buy	244,542 +15,226	+7%	+$2.2M	0.08%	260
2024 Q4	$30M	Sell	229,316 -5,468	-2%	-$766K	0.06%	295
2024 Q3	$36.6M	Buy	234,784 +944	+0.4%	+$152K	0.08%	247
2024 Q2	$36.5M	Buy	+233,840	New	+$35.2M	0.09%	227

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AZN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $1.42M and leaving 60,478 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #639.

Mirae Asset Global ETFs Holdings first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $38.7M in Q4 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Mirae Asset Global ETFs Holdings held 60,478 shares of AstraZeneca worth $11.4M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 7,563 AstraZeneca shares in Q2 2026, an estimated $1.42M.
AstraZeneca made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #639 holding.
Mirae Asset Global ETFs Holdings first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's AstraZeneca position peaked at $38.7M in Q4 2025.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.